MedTrace Logo

Home-sampling in Partner Notification of Chlamydia

NCT01596946 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 633

Last updated 2012-05-11

No results posted yet for this study

Summary

Though partner notification is mandatory to perform of Chlamydia trachomatis infected individuals in Sweden, there was a 10-15% annually increase of reported cases between 1997 and 2007 indicating that partner notification may not be effective in preventing transmission. The investigators wanted to determine whether there was any difference in time between home-sampling and clinical testing as a tool of partner notification measured from eliciting of partners to date of testing.

Conditions

  • Chlamydia

Interventions

BEHAVIORAL

Contact tracing mode test at clinic

BEHAVIORAL

Self-sampling at home - Sent Test Kit

Sponsors & Collaborators

  • Medical Research Council of Southeast Sweden

    collaborator OTHER_GOV

  • Ostergotland County Council, Sweden

    lead OTHER

Principal Investigators

  • Lars Falk, MD PhD · Östergötland CC

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2011-10-31
Completion
2011-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01596946 on ClinicalTrials.gov